April 29, 2026
5 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
The injection of immunotherapy directly into precancerous oral lesions may reduce risk for progression to cancer and help some patients avoid potentially debilitating surgery, according to study results.The size of treated lesions decreased on average by more than half and a majority remained cancer free after 1 year, findings presented at American Association for Cancer Research Annual Meeting
April 29, 2026
5 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

An experimental cancer injection has shown promising results in a clinical trial, shrinking or eliminating tumors in some…

Preoperative radiation therapy targeting brain metastases can activate immune pathways that typically are suppressed, results of…

A new cancer study is attracting global attention after researchers reported that injecting an experimental immunotherapy into a…

Regimen showed benefit in advanced head and neck cancer

Subcutaneous amivantamab induced rapid and durable responses among patients with HPV-unrelated recurrent or metastatic head and…

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago